Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist.
about
Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptorCloning and characterization of murine 1-acyl-sn-glycerol 3-phosphate acyltransferases and their regulation by PPARalpha in murine heartDifferential effects of lysophosphatidic acid and phosphatidylinositol 4,5-bisphosphate on actin dynamics by direct association with the actin-binding protein villinLysophosphatidic acid (LPA) signaling in human and ruminant reproductive tractRole of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapyLipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activityThe heterotrimeric G protein subunits Gα(q) and Gβ(1) have lysophospholipase D activityNew members of the mammalian glycerophosphodiester phosphodiesterase family: GDE4 and GDE7 produce lysophosphatidic acid by lysophospholipase D activityThe Bulk of Autotaxin Activity Is Dispensable for Adult Mouse LifeIdentification of an insulin-regulated lysophospholipase with homology to neuropathy target esteraseLysophosphatidic acid activates peroxisome proliferator activated receptor-γ in CHO cells that over-express glycerol 3-phosphate acyltransferase-1Lysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3.Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA1, LPA2, and LPA3.Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice.International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.alpha- and beta-substituted phosphonate analogs of LPA as autotaxin inhibitorsLysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure.Role of LPA4/p2y9/GPR23 in negative regulation of cell motilityThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsThe Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors.Rho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acidA phospholipid uptake system in the model plant Arabidopsis thaliana.Molecular mechanisms involved in hepatic steatosis and insulin resistance.Regulation of Triglyceride Metabolism. II. Function of mitochondrial GPAT1 in the regulation of triacylglycerol biosynthesis and insulin actionAnticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.LPA induces IL-6 secretion from aortic smooth muscle cells via an LPA1-regulated, PKC-dependent, and p38alpha-mediated pathwayPeroxisome Proliferator-Activated Receptor γ Regulates the Expression of Lipid Phosphate Phosphohydrolase 1 in Human Vascular Endothelial Cells.PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesisLPA receptor signaling: pharmacology, physiology, and pathophysiology.Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligandPhosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases.Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid.ATX-LPA receptor axis in inflammation and cancer.Novel lysophosphoplipid receptors: their structure and function.Lysophosphatidic acid in atherosclerotic diseasesAiming drug discovery at lysophosphatidic acid targets.Lysophosphatidic acid-operated K+ channels.Endogenous ligands for nuclear receptors: digging deeper.Lysophosphatidic acid increases the electrophysiological instability of adult rabbit ventricular myocardium by augmenting L-type calcium current
P2860
Q21245560-CADECB66-94BB-477C-B611-77C25DFBA513Q24302424-4501AE7B-6361-4A43-8DD3-FB9877019E00Q24303951-79A41125-0E68-494E-B195-7881BA8C93E7Q24322768-3486550F-104E-4597-A345-0D451690C560Q26829938-3C0954A1-D4B3-43C0-BC3F-E8C1D0569054Q27015257-4C2FADE5-F795-4AD4-BEBA-BF353E3BE8FEQ28156404-0D53F81E-5658-4444-905F-9198A9937407Q28504918-396B72B8-DE86-4370-BF14-9AD0AAEC026FQ28509679-C0C441CB-1D2B-4490-8180-FADD1E6E29F1Q28550987-9FE2F9A0-2025-4645-8DEC-39BFB0CB4BE2Q28594789-018E1025-C599-4990-AF14-D388ECF4D2A7Q28740882-B1E3D1C3-359B-4A2F-BE43-99F526FB7F5BQ30253010-D09401E9-0A80-469E-A857-4ABB911BC57CQ30400167-F180422C-0B9A-4CE3-8016-658DAEB361C0Q30410474-122BBB04-24B1-49DB-9628-19422588C322Q30429523-3EF0C46E-E634-4CBF-8362-4BD66EE67E5DQ30435432-BE908DCF-87FF-4D71-B92C-7307C85E3046Q30440269-926F1D67-5119-4664-A662-D52A10443268Q30440331-85987258-AFA3-43E6-A288-C0CC0EE089A3Q30486707-5626D5E2-516E-4719-8CD8-FD13726B4FCAQ30486738-C0D4C395-4907-47BC-89D2-80DFA7FA18FAQ30538666-C08F2178-9655-40E5-8E4D-996ED6214EB9Q33361191-0D27E9CC-BB39-4739-8021-21C8E98B9D27Q33585604-8279192E-4A4C-4829-8B97-C8559A61406BQ33641569-EDE5FF1A-F31F-461F-8C02-724B575F5FE6Q33692555-1B5922A6-9F1D-4322-A3F6-0E5AF84C50E7Q33727578-514F2045-4057-45BF-B49A-3981BE854A37Q33738646-52E28435-E727-45A0-916C-3D6AD086A5C2Q33745028-EDBE67EF-5DBF-49FA-A83B-98769C80EE0CQ33825153-44FC61DE-BC74-4DB6-82C3-5682CF1F4B41Q33849597-97895039-A7E5-4CD5-9616-8428C2C5CCECQ33871978-BDF5BB80-9CC6-4064-9D47-C3B75D7BC600Q33955207-12F48D9E-A7B8-4D72-A05E-4A98F6EC0358Q34199719-A20EF5B6-F1C3-4D50-BE9B-895EC5B9693FQ34238610-71FD15B0-8F75-46A4-A452-90B7012470B8Q34273486-2596F372-7D56-4DB8-A17D-3E705B4E1B0CQ34339759-C6277A77-824C-4909-81F3-5A6C77D074B8Q34372355-CA47370D-C297-46F0-B368-85FE4F5768D6Q34412495-2D481B62-D81A-400D-8464-A5AB4C3458BEQ34430249-3DA82620-1EA1-4123-B390-CCB1A18E7F19
P2860
Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Identification of an intracell ...... anscellular PPARgamma agonist.
@ast
Identification of an intracell ...... anscellular PPARgamma agonist.
@en
Identification of an intracellular receptor for lysophosphatidic acid
@nl
type
label
Identification of an intracell ...... anscellular PPARgamma agonist.
@ast
Identification of an intracell ...... anscellular PPARgamma agonist.
@en
Identification of an intracellular receptor for lysophosphatidic acid
@nl
prefLabel
Identification of an intracell ...... anscellular PPARgamma agonist.
@ast
Identification of an intracell ...... anscellular PPARgamma agonist.
@en
Identification of an intracellular receptor for lysophosphatidic acid
@nl
P2093
P2860
P356
P1476
Identification of an intracell ...... anscellular PPARgamma agonist.
@en
P2093
Aaron V Pontsler
Andy St Hilaire
Glenn D Prestwich
Guy A Zimmerman
Hiroyuki Arai
Jerald C Hinshaw
Kotaro Hama
Thomas M McIntyre
P2860
P304
P356
10.1073/PNAS.0135855100
P407
P577
2002-12-26T00:00:00Z